Home › NDC Lookup › RxCUI directory › RxCUI 208406

Sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension [Sulfatrim] — RxCUI 208406

RxNorm drug concept · Semantic branded drug
RxCUI 208406 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI208406
Official nameSulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension [Sulfatrim]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSMX 40 MG/ML / TMP 8 MG/ML Oral Suspension [Sulfatrim]; SULFATRIM 200 MG / 40 MG in 5 mL Oral Suspension; Sulfatrim (sulfamethoxazole 200 MG / trimethoprim 40 MG) per 5 ML Oral Suspension
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)8,640 prescriptions · 38 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trimethoprim: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Trimethoprim is an antibiotic used to treat uncomplicated urinary tract infections — the kind that aren't complicated by other conditions. It works against several specific bacteri...
  • The usual course is 10 days — taken either twice a day (roughly every 12 hours) or once a day, depending on what your doctor prescribed. Try to take it at the same time each day to...
  • How long do I need to take it, and does it matter what time of day I take it?
  • The most common side effects are a skin rash and itching — these are generally mild and tend to show up about a week or two into treatment. Stomach upset, nausea, or a sore mouth c...
📖 Read our full Trimethoprim guide →

🕸️ Concept Web — How Sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension [Sulfatrim] RxCUI 208406

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Sulfamethoxazole 10180
    • Trimethoprim 10829
    • Sulfamethoxazole / trimethoprim 10831
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sulfatrim 220091
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sulfamethoxazole / trimethoprim Oral Suspension 374233
    • Sulfamethoxazole / trimethoprim Oral Liquid Product 1162982
    • Sulfamethoxazole / trimethoprim Oral Product 1162983
    • Sulfamethoxazole / trimethoprim Oral Suspension [Sulfatrim] 220093
    • Sulfatrim Oral Liquid Product 1183775
    • Sulfatrim Oral Product 1183776
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension SCD · 313134
  • Sulfamethoxazole 40 MG/ML SCDC · 316745
  • Trimethoprim 8 MG/ML SCDC · 316867
  • Sulfamethoxazole / trimethoprim Oral Suspension SCDF · 374233
  • Sulfamethoxazole / trimethoprim Oral Liquid Product SCDG · 1162982
  • Sulfamethoxazole / trimethoprim Oral Product SCDG · 1162983

Brand-Name Concepts

  • Sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML [Sulfatrim] SBDC · 569104
  • Sulfamethoxazole / trimethoprim Oral Suspension [Sulfatrim] SBDF · 220093
  • Sulfatrim Oral Liquid Product SBDG · 1183775
  • Sulfatrim Oral Product SBDG · 1183776
  • Sulfatrim BN · 220091

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 208406 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-0854-16 473 mL in 1 BOTTLE (0121-0854-16) SULFATRIM PAI Holdings, LLC dba PAI Pharma 1983-07-03
50090-7836-00 473 mL in 1 BOTTLE (50090-7836-0) SULFATRIM A-S Medication Solutions 2025-12-29
67296-1657-01 100 mL in 1 BOTTLE (67296-1657-1) SULFATRIM RedPharm Drug, Inc. 1983-07-01
67296-1657-02 200 mL in 1 BOTTLE (67296-1657-2) SULFATRIM RedPharm Drug, Inc. 1983-07-01
68788-7345-04 473 mL in 1 BOTTLE (68788-7345-4) SULFATRIM Preferred Pharmaceuticals, Inc. 2020-06-01
Observed labelers: RedPharm Drug, Inc. (2) · A-S Medication Solutions (1) · PAI Holdings, LLC dba PAI Pharma (1) · Preferred Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0570
Range $0.0570–$0.0570 · middle 50% $0.0570–$0.0570 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.